Shandong Xinhua Pharmaceutical Co Ltd (000756) - Total Liabilities

Latest as of June 2025: CN¥3.87 Billion CNY ≈ $566.69 Million USD

Based on the latest financial reports, Shandong Xinhua Pharmaceutical Co Ltd (000756) has total liabilities worth CN¥3.87 Billion CNY (≈ $566.69 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 000756 cash flow metrics to assess how effectively this company generates cash.

Shandong Xinhua Pharmaceutical Co Ltd - Total Liabilities Trend (2015–2024)

This chart illustrates how Shandong Xinhua Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Shandong Xinhua Pharmaceutical Co Ltd's assets to evaluate the company's liquid asset resilience ratio.

Shandong Xinhua Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Shandong Xinhua Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Sabine Royalty Trust NYSE:SBR	USA	$752.82K
Jiangyin Electrical Alloy Co Ltd SHE:300697	China	CN¥983.62 Million
Foshan Electrical and Lighting Co Ltd SHE:000541	China	CN¥6.71 Billion
Vitec Software Group AB (publ) ST:VIT-B	Sweden	Skr5.43 Billion
MAP Aktif Adiperkasa Tbk PT JK:MAPA	Indonesia	Rp4.94 Trillion
Pantoro Limited F:RKN	Germany	€183.49 Million
Sopharma AD WAR:SPH	Poland	zł1.04 Billion
Lily Group Co Ltd SHG:603823	China	CN¥715.05 Million

Liability Composition Analysis (2015–2024)

This chart breaks down Shandong Xinhua Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shandong Xinhua Pharmaceutical Co Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.27	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.76	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.42	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shandong Xinhua Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shandong Xinhua Pharmaceutical Co Ltd (2015–2024)

The table below shows the annual total liabilities of Shandong Xinhua Pharmaceutical Co Ltd from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥3.80 Billion ≈ $556.37 Million	+8.31%
2023-12-31	CN¥3.51 Billion ≈ $513.68 Million	-10.34%
2022-12-31	CN¥3.92 Billion ≈ $572.92 Million	+6.37%
2021-12-31	CN¥3.68 Billion ≈ $538.63 Million	-0.56%
2020-12-31	CN¥3.70 Billion ≈ $541.67 Million	+11.31%
2019-12-31	CN¥3.33 Billion ≈ $486.62 Million	+6.60%
2018-12-31	CN¥3.12 Billion ≈ $456.50 Million	+15.79%
2017-12-31	CN¥2.69 Billion ≈ $394.25 Million	+1.92%
2016-12-31	CN¥2.64 Billion ≈ $386.82 Million	+5.40%
2015-12-31	CN¥2.51 Billion ≈ $367.01 Million	--

About Shandong Xinhua Pharmaceutical Co Ltd

SHE:000756 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.02 Billion

CN¥6.97 Billion CNY

Market Cap Rank

#9030 Global

#2410 in China

Share Price

CN¥14.08

Change (1 day)

-1.26%

52-Week Range

CN¥13.86 - CN¥18.15

All Time High

CN¥44.80